LeonaBio (LONA) Non-Current Assets (2019 - 2026)
LeonaBio (LONA) posted quarterly Non-Current Assets of $2.4 million for Q1 2026, down 34.75% year-over-year from $3.7 million in Q1 2025, and down 11.33% quarter-over-quarter from $2.7 million in Q4 2025.
LeonaBio (LONA) Non-Current Assets (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Non-Current Assets for 8 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 34.75% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $11.4 million (down 30.35% YoY), while the FY2025 annual figure was $2.7 million, down 31.62% from the prior year.
- Non-Current Assets declined to $2.4 million in Q1 2026 per LONA's latest filing, from $2.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $50.6 million in Q4 2022 and bottomed at $2.4 million in Q1 2026.
- Historically, Non-Current Assets has averaged $16.2 million across 5 years, with a median of $4.8 million in 2024.
- On a YoY basis, Non-Current Assets climbed as much as 9.06% in 2023 and fell as far as 89.1% in 2023.
- LeonaBio's Non-Current Assets stood at $50.6 million in 2022, then sank by 89.1% to $5.5 million in 2023, then fell by 28.61% to $3.9 million in 2024, then sank by 31.62% to $2.7 million in 2025, then dropped by 11.33% to $2.4 million in 2026.
- Business Quant data shows LONA's Non-Current Assets at $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.69 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 6.20 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Mar 31, 2023 | 39.88 Mn |
| Dec 31, 2022 | 50.62 Mn |
| Sep 30, 2022 | 45.21 Mn |
| Jun 30, 2022 | 36.15 Mn |
| Mar 31, 2022 | 43.85 Mn |
| Dec 31, 2021 | 71.21 Mn |
| Sep 30, 2021 | 108.34 Mn |
| Jun 30, 2021 | 69.63 Mn |